Article
Re: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-702.
Journal of medical economics - 1 Nov 2017
Patel Jayeshkumar, Zhao Xiaohui, Shah Drishti, Alhussain Khalid, Kamal Khalid
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.